verapamil has been researched along with Typhoid Fever in 1 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Typhoid Fever: An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hingorani, AD | 1 |
Cross, J | 1 |
Kharbanda, RK | 1 |
Mullen, MJ | 1 |
Bhagat, K | 1 |
Taylor, M | 1 |
Donald, AE | 1 |
Palacios, M | 1 |
Griffin, GE | 1 |
Deanfield, JE | 1 |
MacAllister, RJ | 1 |
Vallance, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Double-blind, Randomised, Placebo-controlled Parallel Study to Investigate the Effect of Dietary Nitrate on a Model of Vascular Dysfunction in Healthy Volunteers[NCT02715635] | Phase 1 | 78 participants (Actual) | Interventional | 2016-04-30 | Completed | ||
Investigation of the Influence of Gender on Cardiovascular Function and Inflammation[NCT01582321] | Early Phase 1 | 56 participants (Anticipated) | Interventional | 2012-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for verapamil and Typhoid Fever
Article | Year |
---|---|
Acute systemic inflammation impairs endothelium-dependent dilatation in humans.
Topics: Acetylcholine; Adult; Analysis of Variance; Bacterial Vaccines; Blood Flow Velocity; Brachial Artery | 2000 |
Acute systemic inflammation impairs endothelium-dependent dilatation in humans.
Topics: Acetylcholine; Adult; Analysis of Variance; Bacterial Vaccines; Blood Flow Velocity; Brachial Artery | 2000 |
Acute systemic inflammation impairs endothelium-dependent dilatation in humans.
Topics: Acetylcholine; Adult; Analysis of Variance; Bacterial Vaccines; Blood Flow Velocity; Brachial Artery | 2000 |
Acute systemic inflammation impairs endothelium-dependent dilatation in humans.
Topics: Acetylcholine; Adult; Analysis of Variance; Bacterial Vaccines; Blood Flow Velocity; Brachial Artery | 2000 |